Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1994 Jul;53(7):450–454. doi: 10.1136/ard.53.7.450

Immunohistochemical markers for arthritis in psoriasis.

D J Veale 1, L Barnes 1, S Rogers 1, O FitzGerald 1
PMCID: PMC1005369  PMID: 7944617

Abstract

OBJECTIVES--To examine the immunohistological features in the involved skin of patients with psoriatic arthritis (PA) (n = 15), compared with those in involved skin from patients with psoriasis but no arthritis (n = 5), and with a group with normal skin (n = 4), to identify markers for arthritis in psoriasis. METHODS--Skin was obtained from patients by 6 mm punch biopsy and normal skin was provided by the department of plastic surgery. Samples were stained with monoclonal antibodies against T cells (CD3, CD8, CD4, CD45Ro), B cells (CD20), macrophages (mac387), vascular endothelium (FVIII-related antigen) and a Langerhan's cell marker (p155). The number of cells/vessels staining with each monoclonal antibody was calculated and serial sections of skin were examined to estimate the presence of DR+ keratinocytes. RESULTS--There were significantly more CD45Ro T-cells and blood vessels in patients with psoriatic arthritis compared with both psoriasis alone, and with normal controls (p < 0.02). While B-cells were not seen in psoriasis without arthritis or in normal skin, a small but significant number were observed in PA (p < 0.02). Furthermore, while DR+ keratinocytes were present in both psoriatic arthritis and psoriasis skin, there were significantly more DR+ cells in the psoriatic arthritis epidermis compared with psoriasis alone (p < 0.02). CONCLUSIONS--This study suggests that increased numbers of CD45Ro T-cells, greater vascularity, the presence of B-cells, and increased numbers of DR+ epidermal cells are markers for arthritis in patients with psoriasis.

Full text

PDF
451

Images in this article

452Image
on p.452
452Image
on p.452
453Image
on p.453
453Image
on p.453

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alegre V. A., MacDonald D. M., Poulter L. W. The simultaneous presence of Langerhans' cell and interdigitating cell antigenic markers on inflammatory dendritic cells. Clin Exp Immunol. 1986 May;64(2):330–333. [PMC free article] [PubMed] [Google Scholar]
  2. Baker B. S., Swain A. F., Fry L., Valdimarsson H. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol. 1984 May;110(5):555–564. doi: 10.1111/j.1365-2133.1984.tb04678.x. [DOI] [PubMed] [Google Scholar]
  3. Baker B. S., Swain A. F., Griffiths C. E., Leonard J. N., Fry L., Valdimarsson H. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. Clin Exp Immunol. 1985 Sep;61(3):526–534. [PMC free article] [PubMed] [Google Scholar]
  4. Barker J. N., Jones M. L., Swenson C. L., Sarma V., Mitra R. S., Ward P. A., Johnson K. J., Fantone J. C., Dixit V. M., Nickoloff B. J. Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-gamma. J Immunol. 1991 Feb 15;146(4):1192–1197. [PubMed] [Google Scholar]
  5. Braverman I. M., Yen A. Microcirculation in psoriatic skin. J Invest Dermatol. 1974 May;62(5):493–502. doi: 10.1111/1523-1747.ep12681007. [DOI] [PubMed] [Google Scholar]
  6. Eedy D. J., Burrows D., Bridges J. M., Jones F. G. Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ. 1990 Apr 7;300(6729):908–908. doi: 10.1136/bmj.300.6729.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Farber E. M., Nall L. Epidemiology in psoriasis research. Hawaii Med J. 1982 Nov;41(11):430–442. [PubMed] [Google Scholar]
  8. Gottlieb A. B., Lifshitz B., Fu S. M., Staiano-Coico L., Wang C. Y., Carter D. M. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med. 1986 Oct 1;164(4):1013–1028. doi: 10.1084/jem.164.4.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Griffiths C. E., Powles A. V., Leonard J. N., Fry L., Baker B. S., Valdimarsson H. Clearance of psoriasis with low dose cyclosporin. Br Med J (Clin Res Ed) 1986 Sep 20;293(6549):731–732. doi: 10.1136/bmj.293.6549.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Griffiths C. E., Voorhees J. J., Nickoloff B. J. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol. 1989 Apr;20(4):617–629. doi: 10.1016/s0190-9622(89)70073-6. [DOI] [PubMed] [Google Scholar]
  11. Groves R. W., Allen M. H., Barker J. N., Haskard D. O., MacDonald D. M. Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol. 1991 Feb;124(2):117–123. doi: 10.1111/j.1365-2133.1991.tb00419.x. [DOI] [PubMed] [Google Scholar]
  12. Hellgren L. Association between rheumatoid arthritis and psoriasis in total populations. Acta Rheumatol Scand. 1969;15(4):316–326. doi: 10.3109/rhe1.1969.15.issue-1-4.40. [DOI] [PubMed] [Google Scholar]
  13. Lisi P. Investigation on Langerhans cells in pathological human epidermis. Acta Derm Venereol. 1973;53(6):425–428. [PubMed] [Google Scholar]
  14. Moll J. M., Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55–78. doi: 10.1016/0049-0172(73)90035-8. [DOI] [PubMed] [Google Scholar]
  15. Morganelli P. M., Guyre P. M. IFN-gamma plus glucocorticoids stimulate the expression of a newly identified human mononuclear phagocyte-specific antigen. J Immunol. 1988 Apr 1;140(7):2296–2304. [PubMed] [Google Scholar]
  16. Nickoloff B. J., Karabin G. D., Barker J. N., Griffiths C. E., Sarma V., Mitra R. S., Elder J. T., Kunkel S. L., Dixit V. M. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol. 1991 Jan;138(1):129–140. [PMC free article] [PubMed] [Google Scholar]
  17. Sany J., Clot J. Immunological abnormalities in psoriatic arthropathy. J Rheumatol. 1980 Jul-Aug;7(4):438–444. [PubMed] [Google Scholar]
  18. Shimizu Y., Shaw S., Graber N., Gopal T. V., Horgan K. J., Van Seventer G. A., Newman W. Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature. 1991 Feb 28;349(6312):799–802. doi: 10.1038/349799a0. [DOI] [PubMed] [Google Scholar]
  19. Veale D., Yanni G., Rogers S., Barnes L., Bresnihan B., Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum. 1993 Jul;36(7):893–900. doi: 10.1002/art.1780360705. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES